[Video] The Insulin Journey

The history of insulin is a 100 years story. This marvel has become a blessing for Type 1 Diabetic Mellitus (T1DM) patients. This video describes the complete journey of insulin from even before its scientific discovery. 


Related article: A Century-Long Journey Of Type 1 Diabetes Management: From Insulin To…??

For more videos and discussions on T1DM, visit: https://www.t1dm.org

For queries or feedback, email info@t1dm.org or simply leave a comment below.
Location: Pune, Maharashtra, India

Comments

Post a Comment

Related Articles

A Century-long Journey of Type 1 Diabetes Management: From Insulin to …???

Image
Can you answer this question mark in the title? What is the next product coming in the market for reversing or managing type 1 diabetes?  The history of type 1 diabetes (T1DM) is a longstanding story. However, its management became possible only after the discovery of insulin by Frederick Banting and Charles Best in 1921. With this, scientists started developing hopes to cure this disease. Unfortunately, this goal is yet to be accomplished. This article gives a tour of the various advancements in managing T1DM and how still there is no cure for this perilous disease. Insulin: The First Weapon to Fight T1DM The discovery of insulin was not by chance, it was a very well-thought science. The cascade goes as follows: 1889 : Joseph von Mering and Oskar Minkowski observed that removing the pancreas from dogs developed diabetes in them, followed by their death shortly. 1910 : Sir Edward Albert Sharpey-Schafer projected that the lack of a specific chemical produced by the pancreas is responsib
Continue Reading

[Video] Stem Cell Therapy In Diabetes - Regenerative Medicine

Image
My lecture at the DISCT (Diabetes, Insulin and Stem Cell Therapy) Masterclass, hosted by CliMed Research Solutions on the topic of 'Regenerative Medicine: A Newer Approach For Autoimmune Diabetes'. My special thanks to Dr Ajit Singh for this opportunity!  The following video is a deep dive into this approach: For more publications and discussions on T1DM, visit: https://www.t1dm.org   For queries or feedback, email info@t1dm.org  or leave a comment below.
Continue Reading

[Review Paper] Managing Type 1 Diabetes from Gynecological Waste: Trash to Treasure

Image
Abstract : Type 1 diabetes mellitus (T1DM), an autoimmune disease, involves the destruction of pancreatic β cells. β cells maintain glucose homeostasis by identifying blood glucose and accordingly releasing insulin in order to maintain normal physiologic glucose levels. Human umbilical cord blood (hUCB) cells posture a lesser risk of viral contamination as there is low placental transmission during prenatal life. Additionally, they have advantages such as non-invasive harvest procedure gynaecological waste, low immunogenicity, easy expansion in-vitro, and easy ethical access as compared to deriving stem cells from other sources. According to the published preclinical data infusion of autologous cord blood cells is considered to be safe as they are non-antigenic. Depending on the degree of differentiation, the ability to regenerate themselves, and the origin of many stem cell types can be differentiated. The application of stem cells (SCs) embraces the great potential for the management
Continue Reading

Seesaw of Th1 and Th2 in Autoimmune Disorders

Image
Autoimmune diseases stem from imbalances within the functioning of the patient’s immune system. This imbalance is witnessed due to many factors, such as stress, malnutrition, vitamin and mineral deficiencies, inappropriate gut flora, and allergies. These are the common etiologies that are considered while diagnosing any autoimmune disease.  However, this article describes the basic explanation about the mechanism of T-helper (Th) cells disturbing the immune system, as well as the factors causing this imbalance. What are Th1 and Th2? T-helper cells (Th) are an important part of the immune system. They are lymphocytes that recognize foreign pathogens or normal tissues in autoimmune diseases. Cytokines are produced as a response. These Th cells are divided into subgroups: Th1 Th2 Involved in “cell-mediated” immunity Involved in “humoral-mediated” immunity Usually deals with infections by viruses and certain bacteria Usually deals with infections by bacteria, toxins, and allergens Body’s f
Continue Reading

[Review Paper] Managing Type 1 Diabetes from Gynecological Waste: Trash to Treasure

Image
Abstract : Type 1 diabetes mellitus (T1DM), an autoimmune disease, involves destruction of pancreatic β cells. β cells maintains glucose homeostasis by identifying blood glucose and accordingly releasing insulin in order to maintain normal physiologic glucose levels. Human umbilical cord blood (hUCB) cells posture a lesser risk of viral contamination as there is low placental transmission during prenatal life. Additionally, they have advantages such as non-invasive harvest procedure gynecological waste, low immunogenicity, easy expansion in-vitro, and easy ethical access as compared to deriving stem cells from other sources. According to the published preclinical data infusion of autologous cord blood cells is considered to be safe as they are non-antigenic. Depending on the degree of differentiation, the ability to regenerate themselves, and the origin of many stem cell types can be differentiated. The application of stem cells (SCs) embraces great potential for the management of T1DM
Continue Reading

[Meta Analysis] Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes

Image
Background and objective : Type 1 diabetes mellitus is a complex disease defined by the loss of pancreatic cells, which leads to complete insulin insufficiency. The Diabetes Control and Problems Trial defines the aims of Type 1 diabetes therapy as achieving adequate glycaemic control and preventing and avoiding recurrent bouts of hypoglycaemia. Despite ongoing efforts to improve insulin therapy regimens, the actual hormone substitute therapy treats just the symptoms of the disease, with no influence on disease pathology or etiopathogenesis. In recent decades, there has been a lot of interest in preventative techniques in high-risk patients, based on the theory that if a therapeutic intervention is adopted early in the disease, it can help maintain endogenous cell function by protecting the remaining cell reservoir from autoimmune attack. Authors : Prajakta Kashalikar , Shivani Desai , Avinash Sanap, Madhura Shekatkar, Ramesh Bhonde Journal : Recent Advances in Inflammation & Allerg
Continue Reading

[Video] Pathophysiology and Pharmacology of Type 1 Diabetes Mellitus

Image
I recently delivered a lecture at Masters Certificate Course in Diabetic Pharmacotherapy (MCCDP), hosted by CliMed Research Solutions on the topic of 'Pathophysiology and Pharmacology of Type 1 Diabetes Mellitus'. Special thanks to Dr Ajit Singh for this opportunity!  Understanding the disease's pathophysiology can help in managing it better. The following video is a deep dive into this approach.  For more videos and discussions on T1DM, visit: https://www.t1dm.org For queries or feedback, email info@t1dm.org or simply leave a comment below.
Continue Reading

[Review Paper] Nanotechnology: Newer Approach in Insulin Therapy

Image
Abstract : Insulin is a peptide hormone released by pancreatic beta cells. An autoimmune reaction in diabetes mellitus type 1 causes the beta cells to die, preventing insulin from being produced or released into the bloodstream which impacts 30 million people globally and is linked to shortened lifespan due to acute and chronic repercussions. Insulin therapy aims to replicate normal pancreatic insulin secretion, which includes low levels of insulin that are always present to support basic metabolism, as well as the two-phase secretion of additional insulin in response to high blood sugar - an initial spike in secreted insulin, followed by an extended period of continued insulin secretion. This is performed by combining various insulin formulations that work at varying rates and for different lengths of time. Since the beginning of human insulin use, several advances in insulin formulations have been made to help meet these aims as much as possible, resulting in improved glycaemic contr
Continue Reading

Type 1 Diabetes Mellitus: Aetiology And Pathogenesis

Image
T1DM is allied with the selective destruction of insulin-producing β-cells in the pancreas. The commencement of clinical disease signifies the end stage of β-cell destruction which leads to T1DM. There is marked heterogeneity of the pancreatic lesions, which makes it difficult to follow the pathogenesis of selective β-cell destruction within the islet in T1DM 1 .
Continue Reading

[Review Paper] Nanobiotechnology-Modified Cellular and Molecular Therapy as a Novel Approach for Autoimmune Diabetes Management

Image
Abstract : Several cellular and molecular therapies such as stem cell therapy, cell replacement therapy, gene modification therapy and tolerance induction therapy have been researched to procure a permanent cure for Type 1 Diabetes. However, due to the induction of undesirable side effects, their clinical utility is questionable. These anti-diabetic therapies can be modified with nanotechnological tools for reducing adverse effects by selectively targeting genes and/or receptors involved directly or indirectly in diabetes pathogenesis such as the glucagon-like peptide 1 receptor, epidermal growth factor receptor, human leukocyte antigen [HLA] gene, miRNA gene and hepatocyte growth factor [HGF] gene. This paper will review the utilities of nanotechnology in stem cell therapy, cell replacement therapy, beta-cell proliferation strategies, immune tolerance induction strategies and gene therapy for type 1 diabetes management. Journal : Pharmaceutical Nanotechnology Keywords : Autoimmunity
Continue Reading